PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Reglstered number: 01635916 Charity number: 284881 PENNY BROHN CANCER CARE TRUSTEES, REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2023 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS CONTENTS PAGE Reference and Administrative Details of the Charity, its Trustees and Advisers Independent Auditor's Report on the Financial Slalemenls 18 Consolidated Statement of Financial Activities 21 Consolidated Balance Sheet 23 Charity Balance Sheet 23 Consolidated Statement of Cash Flows 24 Notes lo the Financial Slalements 25 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS REFERENCE ANO ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS Trustees Alex Hamillon-Baily' Istepped down 12.05.20231 Bina Shah ' (appointed 12.05.2023} Charles Russell-smith Charlotte While ' Dr Penny Kechagioglou ' Jacqueline Graves ' Jayne Tucker, (appointed 27.10.20231 Jessica Brohn Jonathan Green ' Kale de Lord 4 (appointed 12.05.2023) Mohammed Saddiq ' Islepped down 12.05.2023} Nicola Newton (appointed 12.05.2023) Rebecca Granger (stepped down 12.05.20231 Rev Dr Victor Badey ' Islepped down 12.05.2023} Stephen Rosser ' Bronwen Wright (appointed 10.05.20241 Amanda Hill lappoinled 10.05.20241 Harvey Marcus lappoinled 10.05.20241 Emma Wallis lappoinled 10.05.20241 (stepped down 09.05.20231 Sub-committees 1. Finan￿ and Audit Committee, 2. People, Culture and Inclusion Committee, 3. Commercial Committee 4. Services Committee 5. Fundraising and Marf(eling Committee Company Registered Number 01635916 Charity Registered Number 284881 Registered Office Chapel Pill Lane, Pill, Bristol, BS20 OHH Company Secretary Lisa Day Chief Executive Officer Andrew Hufford Independent Audltors Burton Sweet Limited The Clock Tower 5 Farfeigh Court Old Weston Road Flax Bourton Bristol BS48 1 UR "We need more than medicine to live well with cancer. We need to care for our mind. emotions, spiriTt. heart and soul." Penny Brohn. 1980 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS TRUSTEES. REPORT.. FOR THE YEAR ENDED 30 NOVEMBER 2023 Welcome to our Annual Report and Accounts for the period 1 December 2022 to 30 November 2023 We are delighted to have continued lo offer our unique services, free of charge to people with cancer in 2023 reaching 1966 clients through Penny Brohn Cancer Care (Penny Brohn UK is the working name of Penny Brohn Can￿r Carel servI￿s. Our personalised and eViden￿-baSed can￿r services gave our clients a¢￿sS to a range of integrative can￿r specialists including doctors, nutrilionisls, counsellors, exercise, and lymphoedema experts all of which are showcased through our award-winning weekly Treatment Support Programme. Our services can be a￿SSed both online and face-to-face through our retreat and wellbeing days which are held at our National Centre in Bristol. The gardens here are considered some of Europe's most naturally therapeutic environments. We also continue lo deliver excellence in our unique commercial partnership with Genesiscare. A selection of our cancer services and personalised wellbeing advice was offered to 3289 Genesiscare patients and delivered through their 14 ￿ntreS across the UK. This work provides vital income to support our charitable work and enables us to reach many more people who benefit from our services and advice, as well as championing the case of personalised cancer care. We saw a 230/0 increase in the number of patients accessing the wellbeing support offered by Penny Brohn Cancer Care staff based in Genesiscare cenlres. We a￿ looking forward to reaching the milestone of len years in partnership with Genesiscare in 2024. The key management personnel of the Charity comprise the Board of Trustees and the CEO. With a new CEO in place from December 2022, the charity has worked hard lo recoverfinanually and build on our service delivery following difficult years through the Covid-19 pandemic and cost-of-living crisis. Financial sustainability has been a major priority for 2023, and this has led lo a review of all our resources, balancing this with the ongoing increased demand lo provide free of charge services. Continuing lo identify income generation opportunities through efficient ulilisation of all the charity s assets - in particular the National Centre - remains a priority. We are committed lo ongoing financial sustainability and although our free reserves have delerioraled during 2023 by £85k las compared lo the reststed free reserves in 20221 this was a turnaround compared lo the reduction of £616k in free reserves between 2021 and the restated free reserves for 2022. I would like lo extend my thanks to all those who have supported Penny Brohn Cancer Care this year, particularly those who supported our Emergency Appeal in the Spring, which was launched to enable us lo continue lo offer our free services following our previous year's deficit and the difficult fundraising environment we were faced with. We continued this with our Direct Debil Appeal in the Autumn. Your phenomenal generosity enables us lo be there for people with cancer across the UK, and r( is because of you that we can plan lo offer even more support in 2024. Whilst we continue lo evaluate delivery of our fa￿-to-faCe services following the pandemic we are delighted that the National Centre has become a place which is used regularly by synergistic healthcare training and service delivery organisations generating £544k of revenue la 1300/0 increase on last yearl. This income is pivotal for the charity as it enables us lo pay for the cost of our headquarters ensuring all our fundraising income can go directly towards paying for our can￿r services. Thanks to the generous funding of our loyal funder Walk the Walk, led by their inspirational founder Nina Barough CBE, we have been able to bring back "in person" services to the National Centre in the form of wellbeing days and residential retreats which will be fLJrther expanded in 2024. Our online sessions have continued to be well attended and the redevelopment of our website makes our vital resources and information easier lo awss. Penny Brohn Cancer Care has a great deal to look forward to in 2024. With improved financial stability, a refreshed brand, excellent feedback on our services and a strong, resilient staff team, we will be well-placed lo support the health and wellbeing of many people living with cancer. We look forward lo sharing our personalised cancer care approach with more people and helping clients and their loved ones live well with cancer. On behalf of the Board of Trustees, thank you lo everyone who champions Penny Brohn Cancer Care as we continue lo support people with can￿r through our in-person, online and seK-help resources. This includes our staff, volunteers, fundraisers and partners- we are profoundly grateful for your continued support. Stephen Rosser, Chair of Trustees PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS TRUSTEES REPORT {CONTINUEDI FOR THE YEAR ENDED 30 NOVEMBER 2023 The Trustees of Penny Brohn Cancer Care have pleasure in presenting their report and financial statements for the year ended 30 November 2023. Our report indudes the Director's report. The financial slalemenls comply with the Charities Act 2011, Companies Act 2006, the Memorandum and Articles ofAssociation and Accounting and Reporting by Charities., Slalement of Recommended Practice applicable lo charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (Charities SORP IFRS10211. Penny Brohn Cancer Care (Penny Brohn UK is the working name of Penny Brohn Cancer Care) is the cancer health and wellbeing charity. We help people feel better in mind, body and spirit by offering everybody with cancer a choice of personalised cancer care. All free. safe and backed by research. Our charitable objects To advance health and relieve sickness and distress, especially bul not exclusively in regard to cancer and those affected by IL by such means as the Trustees in their discretion shall decide. Our mission statements Every person with cancer in the UK is able to access and experience the best of integrative cancer care. leading to better outcomes and quality of life. We are working to the following mission slalements.. We will help you feel in better control of your health and wellbeing through cancer, with a range of personalised cancer care. Choose from eating well, keeping active, managing your emotions, staying connected to the things you love, and mLJch more. All provided by a team of healthcare experts. Vve'll also champion the positive impact of personalised cancer care so more people can benefit. Our purpose To put every adult in the UK in better contml of their health and wellbeing through cancer, physically and emotionally. Penny Brohn Cancer Care defines personalised cancer care as- "Bringing together the best of clinical, lifestyle, and evidence-based supportive therapies." Whilst medical interventions directly treat the disease, (x)mplemenl8ryllifeslylelsupportive therapies can.. Give people with cancer a sense of control over their health and wellbeing Increase their physical and emotional resilience. Redu￿ side effects and symptoms and improve quality of lrfe. Increase tolerance of clinical Irealmenls, meaning fewer delays lo Irealmenl schedules. Our strategy focuses on delivering a hybrid service delivery model that is universally available and enables more people with cancer lo access our support. This helps us reach more people with cancer, meet people's specific needs and offer equitable access. The positive impact of a personalised approach for people with cancer is shown consistently in our service evaluations. We believe passionately that socio-economic or geographic circumstances should not be a barrier to the unique cancer support ServI￿S that we offer, and we are committed to SLJPPOrting free and equitable access for all people living with cancer in the UK. PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Our Impact- 2022-2023 Treatment Support Programme- 90 % of clients said it had helped them feel more confident about getting through treatment Client numbers 1966 Penny Brohn UK Service Delivery Retreats - 93 % of clients said their retreat experience helped them to feel more emotionally resilient. Counselling- 670/0 of clients said they felt more in control after their counselling sessions. l-l Nutritional Therapy- 930/0 of clients reported making posilive changes to their diet two weeks after their appointment. ennyBrohn" Cancerwellbeing foreveryone PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Our Impact- 2022-2023 Patient numbers 3,200 The reach = 14 UK centres In partnership with Genesis Care Client impact = 63 % of patients said PBUK wellbeing support service had helped with side effects such as poor sleep, fatigue & hot flushes. Collaboration - Menopause & Fatigue projects PennyBrohn" Cancerwellbelng for everyone PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS OUR ACHIEVEMENTS AND PERFORMANCE Our transformational services We continued lo develop our services and deliver ex￿pIlon8l support for people with cancer through our hybrid services offering in 2023. In total we supported over 1966 people with cancer, through Penny Brohn Cancer Care services provided free of charge and funded through the extraordinary generosity of our funders and donors. Alongside many people a¢￿SSing online services, we supported 177 people through in-person services and 391 people with cancer accessed one-to-one sessions. We also continue to offer a library of resources on our website that anyone can access at any lime. Our service delivery was also funded through our commercial Partnership with Genesiscare. which as well as delThiering income provided support lo 3289 of their patients. .1 recovered more in one session with my Penny Brohn Cancer Care nut￿t￿niSt than countless appointments with other nutritionists. She was able to woth out my issue and made son7e suggestions of changes to my diet but also mindset. I made these changes and she TRANSFORti4ED my lrfe. My energy levels are now so much better and I feel well. Tnjly a wonderful person. Her manner was so supportive, kind andgenerous. And she had taken time to read everything I hadsent herand responded in a thoughtfvl and researched way. And the key thing is she was able to work out what was the matter (something I hadny realised) and I feel like a new person. Jas", Nutrition one-to-one client Online and "on demand" servi￿$ Our online services offer remained strong in 2023 with our flagship doctor led 4-week Treatment Support Programme ITSPI helping a growing number of people lo support their physical and emotional resilience before, during and after cancer treatment. Evaluation of the programme showed outstanding client satisfaction at 4.915 and 1000/0 saying they would recommend the programme to others. We were also delighted lo be awarded the Best Poster prize for TSP at the British Society for Lrfestyle Medicine conference, recognising the quality and impact of the programme. "This was my final Treatment Support Programme session and the course has been incredibly sustaining, informative, supportive and has meaningfully helped me steer my way through cancer treatment. I have leamt a lol - with all that Penny Brohn Cancer ca￿ offers it feels as if I have been taking in the leaming through my poresff The opportunity in the sesgions to ask questions to integrative minded medical professionals and practitioners has been absolutely invaluable and is a real privilege - very many thanks. Thank you for all the care and thought you have shown us all in these sessions." Kris,, Treatn7ent Support Progran7me attendee Our wider online Servi￿ offer induded a range of informative andlor experiential sessions each week, including nutrition, emotional support groups, exercise, yoga, Pilates, relaxation, mindfulness, healing, clinical hypnotherapy, lymphoedema and scar support. We had 96,000 website visits during the year, with our most visited webpages being ourseif-care Resources, our'cancer Support foryou, infomalion page and our'weekly What's On, that lists upcoming sessions. In- erson services Thanks to a generous grant from Walk the Walk, we were able to offer in-person servi￿$ wi(h eigm themed wellbeing days and three residential retreats held al our beautiful ￿ntre al Ham Green near Bristol. 177 people attended in-person services during this year. We will continue to provide and grow these in-person offerings through 2024. "I came to the retreat becaus6 I had so many questions about my diagnosis. The experience of meeting f6 other p8opl& who were so generous in opening up was invaluable. I got to understand a wide range of challeng8s living with canc&r by speaking to other participants. Most important of all for me is that il pul my situation into p&rspective and h8lp8d me make a decision to go ahsad with treatment. I was comforted by knowing there are so many alternativ8 ways to support me when agreeing to go for conventional medicine. The 16 participants w8r& living proof that there is always hope... Anna.. Residential Retreat Attendee PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS One-to-one services One-lo-one consullalions offer an important OPFM)rtunily for people lo share their personal health and wellbeing concems and receive tailored advice from our expert team. In 2023 we delivered over 1000 appointments to 391 people with cancer with our integrative doctors, counsellors, exercise specialists, nutritional therapists, acupuncturists, lymphoedema therapists and scar care practitioners. We also partnered with the National Centre for Inlegralive Medicine {NCIM} lo offer client support. "The counselling ses&ons with Rachel were life changing and I will be forever grateful lo her. She's incredibly knowledgeable, compassionate and changed my cancer joumey for the beller." Em., Counselling one-lo-one attendee Our partnership with Genesiscare celebrated ils ninth year and we were pleased to see the highest numbers in the history of the partnership. 3,289 patients aC￿sSed the Penny Brohn Cancer Care services through Genesiscare centres in 2023 with 14,377 patient interventions {appoinlmentsl. As part of the partnership, Charity Champions {staff across GenesisCare} raise money and raised £9,000 in 2023. In addition, patients who have previously received treatment at Genesiscare independently raised £7,472 for Penny Brohn Cancer Care in 2023. 'With the fitness program from Genesiscare and the help from Penny Brohn Cancer Care it has been a life changing gxperience for me. l am filter and stronger than I have bgen for a long time, exercising and walking daily, eating healthier than l ever have and I have a different view on life. Andy., Genesiscare patient We are committed to ensuring that our support is accessible and relevant to any adult with cancer in the UK regardless of their background and experience, and are taking time lo review what we offer, the language we use and how we market our services, so that we can reach and appeal to those who will most benefit from our unique support. In 2023 we initiated an independent Client Voice group to inform the development of our strategy and services and are seeking to make this group as representative as possible. We are exploring ways lo better meet the need of men with cancer, we are delighted that Prospect, the Bristol & District Proslate Can￿r Group, have their monthly support meetings at the National Centre. We have also introduced travel, hospilalily and childcare bursaries Ithanks lo the Nicola Corry Fund) to ensure that cost is not 8 barrier to people joining our Wellbeing Days and Retreats. A priority for Penny Brohn Cancer Care is that our services are evidence-based, informed by the needs of our clients, and rigorously evaluated. In 2023 we evaluated fourteen of our services using a mix of post session polls, experien￿ and impact measures and surveys. Our Evaluation, Evidence and Insight team grew as we welcomed new staff to support our evaluation work and the development of evidence-based information resources, as well as a volunteer Client Voice Lead. We are particularly pleased that our evaluation data from clients is strong showing that the quality of services and impact on clients remains excellent. We were thrilled that eleven second year medical students chose Penny Brohn Can￿r Care for their student choice placement. The three-week programme included tutorials about integrative cancer with our expert team, the opportunity to observe services and meet clients, and to experiell￿ their own day retreat. The end of pl8￿ment student presentations highlighted the powerful impact of the experience on each individual as well as the importance of such initiatives in positively influencing the future of mainstream healthcare. "Il was amazing to finally be able lo talk to others who knew what I was on about, we all had slories to share and similar experiences. I wish I had known about Penny Brohn Cancer Care sooner, they do amazing work and have amazing facilities. If il wasn t for Pgnny Brohn Cancer Care- I d be still feeling 8 bit losl. Rosemary, Wellbeing D8y attendee PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Financial Sustainability Our aim is to ensure we remove barriers to accessing our services by offering all our services free of charge. 2023 has continued to provide challenges, but we are pleased that our focus on improving our finanaal sustainability by scaling our activity lo align with a sustainable income level is being achieved and we have concluded the 2023 year with an unrestricted deficit of £58k and a restricted surplus of £182k. We have a five- year financial recovery plan which has been followed diligently. the key points being cost control, diversifw'ng income and ensuring disciplined cash control. As part of our cost control measures, we had to make difficult decisions that concerned our staff team. We look the following actions.. flallening the hierarchy, not replacing roles where colleagues had left the organisation, removing temporary contracts, and absorbing responsibilities into the role descriptions of remaining staff. We are incredibly grateful to the whole staff team for their professionalism throughout this process. Unfortunately, this has meant that we've lost some valuable members of staff, but we now have a staff structure which is leaner, with less hierarchy, allowing us lo fund more setvice delivery and prepare carefully for the future of the organisalion. A key pillar of our financial recovery has been the diversification of our income streams, spearheaded by CEO Andrew. We welcomed new sub-tenanls into Ham Green House (the National cent￿ of Penny Brohn Cancer Carel, bringing vital regular income into the charity. Our sub-tenants all have synergistic missions and include the National Centre for Integrative Medicine INCIMI, Vita Health, Natural Academy, Holistic Wellbeing. Somerset and Wessex Eating Disorders Association ISWEDAI, an Osteopath, a Cancer Rehabilitation Specialist, a Psychologist and a Counsellor. These synergistic tenants have enriched the building with their offerings and have brought it new life. We have also had success with galvanising supporters and are thankful for the incredible generosity from existing and new supporters of the charity. Our year-long fundraising campaign aimed to increase transparency with supporters and had regular updates and communication points. Our Emergency Appeal in May 2023 raised over £50,000 and our Autumn Appeal in October 2023 raised over £12,000 in cash gifts plus generating £22,000 annually in regular gifts from new and existing donors. On 28th June we organised a 'thank-a-Ihon', where staff from across the charity spent a day calling and personally thanking supporters. We intend to make this an annual event and wish lo use this opportunity to thank all our generous donors and fundraisers once again for their incredible support this year. Our unrestricted reserves have also improved following the review of a restricted fund legacy as a result of ongoing communications with executors. This has led lo £238k of unrestricted expenditure on lymphoedema services in prior years being allocated to the lymphoedema restricted fund. £50k of such expenditure was allocated against this fund which was boosted by a further £147k of income in the current year. In addition, a significant grant from Walk the Walk of £150k was received in 2023 and wholly recognised, with £94k of this being carried fonNard in a restricted fund to be spent in subsequent years. Strategic Leadership & Govemance In December 2022, Andrew Hufford was appointed as the Chief Executive Officer of Penny Brohn call￿r Care, having previously been on the Executive Leadership Team as the Commercial Director. Andrew committed to a five-year financial recovery plan, and introdu￿d a flatter leadership structure with a Senior Leadership Team which meets once a month to review the financial position and works collaboratively on strategy and operational projects. Two new trustee sul>committees were created.. seNi￿s and Fundraising & Marketing both started this financial year, adding lo the existing sub-tx)mmitlee structure of Finance & Audit, People, Culture & Inclusion, and Commercial. This has helped to provide an improved focus on accounlabilily and governan￿ and gives the Trustees more regular opportunities lo meet with departmental leads, increasing transparency and providing a better oversight of the charity's work. 10 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS At a senior level, we have started imFX)rtant work this year developing our Risk Assessment planning, which ensures the whole team feels prepared and knowledgeable, and slandardising Annual Review pro￿sseS and templates. A fresh look for the charity, informed by the needs of people with cancer This financial year, we completed a brand refresh project, with a new logo, strapline, colour palette and tone of voice for the charity. This update gives Penny Brohn Cancer Care a fresh. modern and exciting visual identity, as well as ensuring that the way we describe our services and ourwork is appealing, appropriate and accessible. This work has helped us increase awareness of the charity and encouraged more people lo support us financially. We were pleased lo be able to take on much of the project in-house, keeping costs to a minimum. Clients were integral to this work, meeting regulady with the Head of Brand, Marketing and Influencing to share their opinions and ideas. Meetings We￿ also held with Penny Brohn Cancer Care staff, volunteers, Trustees, and healthcare professionals lo shape the direction. The refreshed website launched in August 2023 and has had wholly positive feedback so far. Income Generation The fLJndraising team have performed exceptionally well considering the external economic and political environment as well as internal capacity gaps within vital roles, generating 980/0 of ils original budgel1£1.091,563 against a target of £1, 111,9591. Some key highlights indude.. The launch of the Penny Brohn Cancer Care emergency campaign, the aim of which was lo raise much needed funds and communicate effectively with our supporters about the challenges we were facing. The appeal itself launched in the Spring and raised over £50,000 across a broad range of supporters. It was followed with a Direct Debit appeal in the Autumn generating over £15,000 in new regular income each year. We addressed the capacity gap within our Philanthropy Team with the recrLJitmenl of a Philanthropy Manager. This is a vital position and will be instrumental in our financial growth. 2023 was the first full year of proactive digital fundraising and we experienced some fantastic results= Over £12,000 in donations acquired throLJgh digital channels for the emergency Spring appeal. The development and implementation of new email welcome series with a 59.60/0 open rale {14.6 /0 higher than yearly average). Stomp Imass participation event) returned in 2023 with 115 participants, 58 % of these were new supporters lo Penny Brohn Cancer Care. The event raised £15,700, against a target income of £25,000 and 180 participants. Across 2023 we continued to grow our hospitality offering and saw income increase by an amazing 1300/0, to £544,000 for the year. Our National Centre al Ham Green is now well-used by external customers throughout the year, and services include room hi￿, catering, retreat, wellbeing & event space. Also, permanent sub- tenants that have been carefully selected as synergistic organisalions. or individuals, aligned with Penny Brohn Cancer Care's values and ethos, provide regular monthly income. The Hub- our charity shop and wellbeing Spa￿ in Clifton, Bristol - continues lo grow and develop, embedding itself into the local community and signposting to the National Centre and our Website. We are particularly thankful lo a grant from the John James Bristol Foundation for support against the operating costs of The Hub. The Hub provides key unrestricted income for the charity. OUR FUTURE PLANS After a successful year of stabilising costs and generating income, we stay committed to careful financial planning as we move into 2023-24. We have ambitious plans in order to reach more people living with cancer with our services, and our particular focus areas are as follows.. To support more. and more diverse, people with cancer with services that will make the biggest drfference to their health and wellbeing before, during and after treatment. PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Increasing availability of our in-person services, wth monthly Wellbeing Days and seven residential retreats. New Wellbeing Day themes will be offered for people experiencing menopause, mental health concerns as well as men living with cancer. Developing a pre-treatment Iprehabililationl service, as well as more expert support for key side effects and symptoms experienced by most people with cancer. Ongoing financial stabilisalion and continuing to build diversified income generation. It is essential that we focus on income stabilrf(y and sustainability. Achieving the Patient Information Forum IPIF lick) qualty mark for trusted information. Increasing awareness and referrals from health care professionals, other cancer support charities and patient support groups through a new Outreach and Engagement role. Strengthening our focus across the organisalion on equity, diversity, inclusion, and a¢￿ssibIlity. We will focus on this across the organisalion so we can create a stronger and more sustainable organisation. Refreshing our charity values, working with staff lo create a bold, exciting list of values. Celebrating our tenth year of partnership work with Genesiscare and renew our ongoing partnership. Continue lo look at how the six acres of land purchased through the help of a generous donor is 2022 can help us achieve our charitable mission. This is part of our future plans, once Network Rail have confimied decisions regarding the CPO. THANK YOU: To all those using our services. who generously let us into their lives and who continue to inspire us every day. A special thank you to Walk the Walk Worldwide for their generous funding, enabling the return of in- person seNices lo Penny Brohn Cancer Care and paving the way for a truly hybrid delivery model that ensures continued support for those living with cancer. We extend our heartfelt gratitude to two Penny Brohn Cancer Care Trustees,. Stephen Rosser and Jon Green, for their exceptional fundraising endeavours in 2023. Through their individual challenges, they raised £16,923 including gift aid. Whether it was a running or taking on walking challenge, donating, selling up a regular gift, holding a bake sale or raising money in other creative ways, our amazing supporters raised over £350,000. Genesiscare, and our other partners, for their belief and commitment to people with cancer. Our dedicated, loyal and commilled Trustees, volunteers and staff who have continued to work tirelessly throughout the year to deliver the incredible results presented in this report. Finally, a huge thank you to our philanthropic supporters who have generously donated over £90,000. We would also like to thank: Walk the Walk Worfdwide, Newby Trust Limited, Tim Tiley Bursary Fund, The Gerald Micklem Charitable Trust, The Elizabeth And prin￿ Zaiger Trust, The 29th May 1961 Charitable TrLJsI, RJ and AH Daniels Charitable Trust, The Blair Foundation, The Souter Charitsble Trust, Sl. James's Place Charitable Foundation, Webb Family Charitable Trust, Inchcape Foundation, Steven Cooper Charitable Foundation, Community Foundation in Wales, The Annett Trust, The Waller Guinness Charitable Trust, Renishaw Charities Committee, Maclaggart Third Fund, Lillie Johnson Charitable Trust, Quartet Community Foundation, The Helianthus Charitable Trust, The Uxbridge Charitable Trust, The Allen Charitable Trust, Sir Charles Jessel Charitable Trust, The Gilander Foundation, The Burges Salmon Charitable Trust, Leanne & Winston Newman Charitable Trust, Bristol Windows, Weslspring IT, BDO, Baxter Healthcare Ltd, Assura and Audley Redwood Ltd. STRUCTURE, GOVERNANCE AND MANAGEMENT Penny Brohn UK is the working name of Penny Brohn Cancer Care Ithe Charilyl and is a company limited by guarantee, registered on 17 May 1982.11 is governed by Memorandum and Articles of Association. Governance Penny Brohn Cancer Care is governed by a Board of Trustees (the Board). The Board's remit is lo sel the vision, strategy and aims for the charity by its objects, lo manage the financial resources in the best interest of the charity and its beneficiaries and to ensure the charity works in a manner consistent wrf(h ils objectives. The Board met formally five times dLJring 2023. To ensure the Trustee Board has a 360-degree view of all charitable activities there are now five sub- 12 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS committees in place which govern the five core parts of the charity - Finance & Audit, Services, People. Culture & Inclusion. Fundraising & Marketing and Commercial. All committees meet remotely.. During 2023, the Finance & Audit Committee mel four times,. the Services Committee mel four times remotely,. the People, Culture & Inclusion Committee met twice- the Fundraising & Marketing Committee met three times and the Commercial Committee met three times. Trustee appointment, induction and training Trustees are appointed to supply the skills identified as being necessary for the good governance of Penny Brohn Cancer Care. There is a formal recruitment process for finding new Trustees and once appointed. an induction and training process. The induction of new Trustees is tailored to the needs of the individLJal bul includes the provision of key documents and information relating to the charity, a guided tour of the National Centre, introduction to the Chair, Executive Team and other key staff and an outline of the duties. responsibilities and obligations of being a Trustee. Trustees are encouraged to allend external and internal development events where it is felt these will help the execution of their governance role. The temi of office as a Trustee is a three-year period and Trustees may serve up to three temis, except in exceptional circumstances, when the term of office can be longer. All Trustees give their lime voluntarily and receive no payment or benefits from the charity. Trustees must show all relevant interests and register them with the CEO and withdraw from decisions where a potential Conflict of interest might arise. Any expenses reclaimed or related party transactions in the year are set out in note 24 to the financial slalements. Key management The Board delegates the day-to-day running of the charity to a Chief Executive Officer. We have a Senior Leadership Team who meet monthly together and allend trustee sub-commillee meetings in their relevant areas. Public benefit The Trustees of Penny Brohn Cancer Care ensure that the charity carries out its aims and objectives and that these supply public benefit. In doing so the Trustees take into consideration the Charity Commission's guidance on the Public Benefit requirement under the Charities Act 2011. Ourcharitable purpose The charitable aims of the charity, as set out in the Articles of Association, are to advance health and to relieve sickness and distress, especially bul not exclusively about cancer and those affected by it, by such means as the Trustees in their discretion shall decide. Pay policy The pay and reward of the CEO is subject lo the same structure as useij for other employees and is in line with the Executive Pay Policy. This policy is regularly reviewed by the People and Culture Committee with the support of the Trustee Board. Trading Subsidiary The charity has a wholly owned trading subsidiary, PB UK Commercial Ltd, which passes all its taxable profil by way of Gift Aid to further the aims of the Charity. PB UK Commercial Ltd has a Board of Directors, which during the year under review consisted of two Trustees. Penny Brohn Cancer Care owns the entire share capf(al of the subsidiary. Risk Management The Trustees have adopted a risk management strategy which includes.. A risk policy, approved by the Trustees and subject lo annual review. The maintenance of a strategic risk register to review the risks the Charity may face, and the mitigating actions the Charity has taken or can take. The risk register is reviewed at Trustee meetings and risks are scored in terms of both impact and likelihood. Systems, policies, and procedures designed lo minimise impact on the Charity should those risks occur. PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Strategic Risk Register Strategic risks are significant ti*sthat influence the achievement of the Charity's core aims. They might be major internal risks such as financial suslainabilily or compliance risks. Or they may be extemal events with high impact which we rAnnot control and to which we the￿fore need to respond. Key strategic risks were identified as.. Financial sustainability.. This is mitigated by strong financial planning and monitoring underpinned by a strong balance sheet and access lo £1m of a revolving credit facility. We have successfully diversrfied our income St￿amS with the expansion of our hospilalily including the regular sublet income from synergistic organisations. The creation of the Fundraising sub-committee lin tandem with our Commercial sub-commilteel ensures we stay focused on all areas of our income generation. At the same time, we have redLJced our cost base and continue to monitor expenditure within the char((y. Impact of client services.. We must continue lo ensure we are investing in the right and most relevant services lo make maximum impact. Using evidence collated through our Evaluation, Eviden￿ and Insight Team, and from our Client Voice Progmmme, we constantly work lo ensure we support people with cancer in the most effective way. Our services are now offered both online and in person al our National Centre and through 14 Genesis Care ￿ntre8 (our service delivery partner) giving our clients even greater ac￿5$1b111ty. The creation of the servI￿s sub-committee ensures a consistent focus and review of our service offering measuring both impact and reach. Rising costs- We continue lo experien￿ cost pressures across the board but these are being miligaled by constant pricelvalue comparisons and by scrutiny from the finance sub-committee. IT Infrastructure.. To meet the ongoing needs of our staff, services clients and customers in our hospitality business, we will be undertaking a review of our IT infraslruclure, including telephony and software packages, lo ensure that we are maximising our efficiency and ensuring costs are minimised. Fundraising standards At Penny Brohn Cancer Care, we are entirely dependent on the commitment of our supporters and lake our responsibilities lo supporters very seriously. We fundraise in a wide range of ways to maximise our investment in our Msion. Our current fundraising activities include direct mail and email marketing, sponsored challenge and community events and fundraising events. We also welcome legacy and in-memoriam donations, work with grant giving trusts and foundations and corporate partners. Penny Brohn Cancer Care is registered wtth the Fundraising Regulator and is compliant with the standards set by the Regulator in its'code of Fundraising Practice,. We are pleased to make this Commitment and feel il gives our supporters Confiden￿ in our fundraising practices. In addition to this, Penny Brohn Can￿r Care is an organisalional member of the Institute of Fundraising. All fundraising activities are organised directly by Penny Brohn Cancer ca￿ staff. We do not engage third party professional fundraisers or other commercial participators to raise funds on our behalf. We do operate a fundraising lollery, licensed by North Somerset Council. and currently administered extemally for us by Unity Lottery (Sterling Management Centre Limited, a li￿nSed External Lottery Manager IELMI by the Gambling Commission). We ensure that they are compliant with the code and all applicable laws. We also have signposting for responsible gambling advice, self-exclusion information and children and vulnerable persons guidelines provided on our lottery webpage. Across all our fundraising aclivily, we are mindful not to be unreasonably persislenl or lo apply undue pressure on anyone, or lo intrude on anyone's privacy. In every communication, supporters are given the opportunity to unsubscribe or opt out. Penny Brohn Can￿r Care recognises our responsibility and are committed to adhering to the code and acting appropriately and wi(h compassion when engaging with vulnerable or potentially vulnerable people. During this year, we received no complaints relating lo our fundraising activity 14 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Staff Staff have continue to demonstrate their dedication lo the Charity and our work in supporting clients again this year. Although headcounl reduced across the earfy part of 2023, there was a rise during September and October due to additional funding, enabling the creation of fixed-term roles Covering Outreach and Engagement, Evaluation and Services Publicity. The Employee Voice groLJP have gained momentum with a new Chair in place, acting as a vehicle for staff to raise issues, feed their views into the CEO and Trustee Board and bring about positive actions and change. In September, work was concluded on a revised Equality Diversity & Inclusion policy which was approved by the Board with the agreement that a new voluntary staff role would be introduced lo appoint an ED&1 champion. Volunteers Volunteers continue to play a valuable role within the charity, enabling fundraising events such as Open Garden Day and STOMP lo run suc￿SsfUlly. A core group of volunteers give their time on a weekly basis with an average monthly total of 430 hours per month with each department within the organisation benefiting, including the Penny Brohn UK HUB lo support a 7 day opening and the Garden team who maintain a therapeutic space for everyone to enjoy. In addition lo this, the charity has welcomed local students for work experien￿ who have added to the growng voluntsry workforce. Clinical governance Clinical governan￿ refers lo assuring the safely and quality of our client facing services which includes face-lo-face, virtual, remote and online resources. Effective quality assurance enables us to ensure that our services are safe, caring, fair, well-led and responsive to client needs. Penny Brohn Cancer Care has developed a clinical governance framework which ensures that clients receive the best and safest care possible. FINANCIAL REVIEW Statement of Financial Activities (SOFA) During the year, the Group received £2.38m in unrestricted income12022= £1.87m)- Restricted income of £380k {2022.. £371 kl was donated resulting in lolal income of £2.76m12022.. £2.24m)- Major sources of funding were received from.. 2023 £'ooo 257 2022 £'ooo 256 Trusts & Grants Services & Strategic partnerships Donations, community & corporate fundraising Legacies Retail & hospitality 868 587 701 380 152 669 351 2761 2244 We have continued lo work in a financially challenging environment but have made good progress in turning around our deficit result from 2022. We were helped in this by the clarification of the temis of a reslricled legacy which meant some current services could be funded by this legacy where they were otherwise not able to be. Also, our income from retail and hospitality grew subslanlially and has meant that expenditure related lo the running of the National Centre is covered by this income source. Our partnership with Genesiscare continues lo thrive and conlribules an important level of income lo cover other charity expenses. Income from grant makers included £150k from Vvalk the Walk, a long-standing supporter and funder of Penny Brohn Cancer Care. PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Balance Sheet Nel assets of the Group increased by £95k. in particular it is worth noting that trade debtors reduced by £112k due lo a more focussed approach to debt collection intr(xluced in the year. Current creditors increased by £42k. Creditors falling due after one year continues lo fall as the charity continued to pay back the Natwesl mortgage on the National Centre. Our general free reserves reduced during the year by £115k, and so tolalled £274k, bul our designated funds, which includes land, increased by £27k taking the value to £5.94m. Reslricled resetves al the end of the year increased by £183k to £244k. PB UK Commerclal Ltd The trading subsidiary carries out all trading activities of Penny Brohn Can￿r Care. The trading subsidiary undertook the hire of room and hospitality servi￿$ at the National Centre and the sale of new goods through the National Cenlre, The Hub and our Online Shop. PB UK Commercial Ltd generated a profil of £62k in 2023 which is a £134k improvement on the previous year. Reserves Policy Penny Brohn Cancer Care's Reserves Policy is to aim lo maintain Free Reserves of 2 times monthly payroll which is close to £300K for the financial year 2023. This is considered a sufficient amount to meet the charity's immediate cash needs. Al November 2023 the free reserves of the charity were £284k and so slightly below the policy level. This amount is reviewed annually and considers The immediate cash ne￿S of the business through cash flow projections Other available cash facilities Assets and Liabilities on the Balance Sheet Risk profile of projected future income In addition lo Free reseNes, the Charity holds credit facility with Natwesl Bank and Triodos Bank of £500K each. This provides a facility to meet any short-term cash needs in excess of 2 months, payroll in the event of significant unforeseen expenditure. The building at Chapel Lane, Pill (National Centrel was revalued in August 2019 by Jones Lang Lasalle Limited, a firm of valuers exlemal lo the Charity. The property's open market value was considered to be £6,100,000 in accordance with the RICS. The Charity currently has a mortgage of circa £900,000 secured on the property. Going Concern The Finance and Audit Committee regularly review various relevant financial reports from the Charity including forecast income and expenditure and cash flow scenarios, to attest positively to the Char(cy s Going Concem Status. This review is shared with the full Trustee Board at each Trustee meeting. The Charity has two committed loan facilities of £500k with each of Natwesl and Tri￿OS banks. Advantage was taken of £200k of this facility for short-tem) working capitsl needs bul this was repaid well before the year end. The Charity plans to continue to hold these debt facilities, secured on the National Centre, that can be used to bridge liming gaps in revenue raising. The Trustees review of the charities forecast and prc4ections leads lo a reasonable expectation that the charity has adequate resources lo continue in operational existence for a period of at least twelve months following the dale of approval of these financial slalements. The group therefore continues lo adopt the going con￿rn basis for preparing ils financial statements. 16 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Statement of tmstees. responsibilities The Iruslees (who are also directors of Penny Brohn Cancer Care for the purposes of company lawl are responsible for preparing the Trustees, Report (incorporating the strategic report and directors, report) and the financial slalemenls in accordance with applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102.. The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Accepted Accounting Praclicel. Company law requires the Iruslees to prepare financial statements for each financial year which give a true and fair view of the stale of affairs of the charitable company and the group and of the income and expenditure, of the charitable group for that period. In preparing these financial statements, the trustees are required lo.. select suitable accounting policies and then apply them consistently., observe the methods and principles in the Charities SORP., make judgments and accounting estimates that are reasonable and prudent: slate whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements,. and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company and the group will continue in business. The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. In so far as the trustees are aware.. there is no relevant audit infomiation of which the charitsble company's auditors are unaware; and the trustees have taken all steps that they ought lo make themselves aware of that information. Approved by order of the members of the Board of Trustees and signed on their behalf by.. Stephen Rosser Chair of Trustees Dale.. 21 August 2024 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Independent auditor's report to the members of Penny Brohn Cancer Care Opinion We have audited the financial statements of Penny Brohn Cancer Care {the 'lhe parent Charity") and its subsidiary, PB UK Commercial Ltd Ilhe 'group'l for the year ended 30 November 2023 which comprise the Consolidated Slalemenl of Financial Activities, the Consolidated Balance Sheet, the Consolidated Cash Flow statement and notes lo the financial slalemenls, induding a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102.. The Financial Reporting Standard applicable in the UK and Republic of Ireland Iunited Kingdom Generally Accepted Accounting Practice). In our opinion, the financial statements.. give a true and fair view of the slate of the group's affairs as al 30 November 2023 and of r(s income and expenditure for the year then ended., have been properly prepared in accordance with United Kingdom Generally A¢￿pted Accx)unting Practice., have been prepared in accordance with the requirements of the Companies Act 2006. Basis for opinion We conducted our audit in accordance with international Standards in Auditing (UK) IISAS IUKII and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial slalemenls section of our report. We are independent of the group in accordance with the ethical requirements that are relevant lo our audit of the financial slalemenls in the UK, including the FRC'S Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate lo provide a basis for our opinion. Conclusions relating to going concem In auditing the financial statements, we have concluded that the directors, use of the going concem basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have perfom)ed, we have not identified any material Un￿rtaInlieS relating to events or conditions that, individually or collectively, may cast significant doubt on the group's ability to continue as a going concern for a period of al least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors wf(h respect to going concem are described in the relevant sections of this report. Other infomiation The trustees are responsible for the other infomiation. The other infomiation comprises the information included in the annual rep)rt other than the financial statements and our auditor's report Ihereon. Our opinion on the financial statements does not cover the other information and, except lo the extent otherwise explicitly stated in our report, we do not express any fomi of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears lo be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required lo determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If based, on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to reFX)rt the fact. We have nothing lo repx)rt in this regard. 18 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS Opinions on other matters prescribed by the Companies Act 2006 In our opinion, based on the work undertaken in the course of the audit.. the information given in the Iruslees, report lincorporaling the directors, report) for the financial year for which the financial statements are prepared is consislenl with the financial statements., and the directors, report has been prepared in accordance with applicable law requirements. Matters on whlch we are requlred to report by exceptlon In the light of our knowledge and understanding of the charity, the group and ils environment obtained in the course of the audit, we have not identified material misstatements in the directors, report. We have nothing to rep)rt in respect of the following mallers in relation lo which the Companies Act 2006 requires us lo report to you if, in our opinion.. adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us., the financial statements are not in agreement with the accounting records and returns., certain disclosures of trustees, remuneration specified by law are not made,. or we have not obtained all the information and explanations necessary for the purFK)ses of our audit,. or the trustees were not entitled lo prepare the financial statements in accordan￿ with the small companies, regime and take advantage of the small companies, exemptions in preparing the directors, report and from the requirement to prepare a strategic report. Responsibilities of trustees As explained more fully in the Iruslees, resr)onsibililies statement, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as they detemiine is necessary to enable the preparation of financial statements that are free from material misstatement. whether due to fraud or error. In preparing the financial stalemenls, the Iruslees are responsible for assessing the Charity's and the Group's ability lo continue as a going concern, disclosing, as applicable, mallers related lo going concern and using the going concern basis of accounting unless the Iruslees either intend to liquidate the Charity or ils subsidiary or lo cease operations, or have no realistic altemalive but to do so. Auditor's responsibilities for the audit of the financial statements Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misslatemenl, whether due to fraud or error, and lo issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, bul is not a guarantee that an audit conducted in accordance with ISAS IUKI will always delect a material misstslement when il exists. Misststemenls can arise from fraud or error and are wnsidered material rf, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial slalemenls. Our approach to identifying and assessing the risks irf material misstatement in respe[* of irregularities, including fraud and non-compliance with laws and regulations, was as follows.. we identified the laws and regulations applicable to the charity and ils subsidiary through discussions th those charged with governan￿ and other management, and from our knowledge and experien of the sector., we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements of the operations of the parent charity and its subsidiary, including the Companies Act 2006. taxation legislation and data protection, anti-bribery, employment, pensions, environmental and health and safely legislation., and we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management, inspecting legal correspondence and remaining alert during the audit for any 19 PENNY BROHN CANCER CARE ANNUAL REPORT AND ACCOUNTS indications of non-compliance. Our audit procedures in relation lo fraud included but were not limited to.. making enquiries of those charged with governance and other management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud., discussing amongst the engagement team the risks of fraud- gaining an understanding of the internal controls in place lo mitigate risks of fraud and non-compliance th laws and regulations., testing joumal entries to identify unusual Iransaclions., assessing whether judgements and assumptions made in determining the accounting estimates set out in the accounting policies were indicative of potential bias,. and investigating the rationale behind significant or unusual transactions. There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required lo identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal corresFx)ndence, if any. Material misstatements that arise due to fraud can be harder to delect than those that arise from error as they may involve deliberate concealment or collusion. A further description of our ￿SponSibl1111es for the audit of the financial statements is located on the Financial Reporting Council's website al www.frc.or .uklaudilorslaudit-assurance-elhicslauditors-res onsibilities-for-Ihe- audit. This description forms part of our auditor's reFX)rt. Use of our report This report is made solely to the Charity's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might stale to the Charity's members those matters we are required to stale in them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Charity's members as a body. for our audit work, for this report, or for the opinions we have formed. Joshua Kingston ACA Isgnior Statutory Auditor) For and on behalf of Burton Sweet Limited Statutory Auditor The Clock Tower 5 Farleigh Court Old Weston Road Flax Bourton Bristol BS48 1 UR Date.. 28 August 2024 20 PENNY BROHN CANCER CARE CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME & EXPENDITURE ACCOUNTI YEAR ENDED 30 NOVEMBER 2023 Unrestrlcted Fund8 Restrlcted Fund8 Total Funds 2023 Total Funds 2022 Note It)com8from'. DDnation5 and legacies Charilabk 8cti¥ilies Othtrtradin9 SCtiviti8S Investrnenls Other Income IR•8tatsdl 1,105,273 793.139 342,428 348 2,500 834.248 878.120 658,621 376 9.725 379.561 1.213,809 878,120 658,621 376 9,725 Total Income 2,381.090 379.561 2.760,651 2.243.688 Expenditure on.. Ra￿Ing funds charitab￿ 8Ctivilies 618.019 1,802,000 618,019 2.047,462 725.921 2,112,632 245.462 Total expendlture 2,420.019 245.462 2.665,481 2.838,553 Net1055es on investment5 14361 14361 Net incomellexpenditurel lorthe year 139.3651 134.099 94,734 1594.8651 Transfers between funds 22 148,4541 48.454 Nat mov8m8nt botw•8n funds 182.553 94,734 1594.8651 Total fund8 at th8 start of th8 yoar la8 pr8vlou8ly 8tst8dl 22 5,442.999 374.790 5.817,789 6.382,654 Prfor yearadlustment 344.389 1313,0131 31,376 61,376 Totsl funds at $tsrt of year Irestatsdl 5,787.388 61.777 5.849,165 6.444,030 Total fund8 at trnd of ￿ar 22 5,699,569 244.330 S.943,899 5.849,165 The Group has no recogn18ed gains or losse8 olhfrrlhan the result8 for the year as sel out above. l of the activthes of the Group are dassed as continuing See note 11 for the comparative Slalemenl of Finanual AclivilEs. Th8 notas on pag&8 25 to 42 fomi part of thotsa firbantial statomon 21 PENNY BROHN CANCER CARE THE CHARITY'S STATEMENT OF FINANCIAL ACTIVITIES IINCLUDING INCOME & EXPENDITURE ACCOUNTI YEAR ENDED 30 NOVEMBER 2023 Unrestrlcted Fund8 Restrlcted Fund8 Total Funds 2023 Total Funds 2022 Note It)com8from'. DDnation5 and legacies Charilabk 8cti¥ilies Othtrtradin9 SCtiviti8S Investrnenls Other Income IR•8tatsdl 1,105,273 793.139 391,271 348 2,500 834.248 878.120 576,067 376 9.725 379.561 1.213,809 878,120 576,067 376 9,725 Total Income 2,298.536 379.561 2.678,097 2.292.531 Expenditure on.. Ra￿Ing funds charitab￿ 8Ctivilies 597.047 1,802,000 597,047 2.047,462 702.207 2,112,632 245.462 Total expendlture 2,399.047 245.462 2.644,509 2.814,839 Net1055es on investment5 14 14361 14361 Net incomellexpenditurel lorthe year 1100.9471 134.099 33,152 1522,3081 Transfers between funds 22 148,4541 48.454 Nat mov8m8nt botw•8n funds 1149.4011 182.553 33,152 1522.3081 Total fund8 at th8 start of th8 yoar la8 pr8vlou8ly 8tst8dl 22 5,515.120 374.790 5.889,910 6.382,218 Prfor yearadlustment 344.389 1313,0131 31,376 61,376 Totsl funds at $tsrt of year Irestatsdl 5,859.509 61.777 5.921,286 6.443,594 Total fund8 at trnd of ￿ar 22 5,710,108 244.330 5.954,438 5.921,286 Tha Cha￿tY has no recognisad galn8 or lossas otsr than the re8uNs forthe year 88 set out above. l of the aclmlies of the charity are classed as continuing See note 11 for the comparative Slalemenl of Finanual AclivilEs. Th8 notas on pag&8 25 to 42 fomi part of thotsa firbantial statomon 22 PENNY BROHN CANCER CARE BALANCE SHEETS AS AT 30 NOVEMBER 2023 Company numbgr.. 91636916 Group 2023 Charlty 2023 Group 2022 Charty 2022 Note IR8statodl IRo8tatedl Fixed assets Intangible 2ssels Tangible assets Investments 28,772 6.357,332 6,565 28.772 6.357,332 6,567 6,332,201 fj.129 6,332.201 6.131 14 6,349.831 6,340.833 6.392,669 6,392,671 Current a8$gt$ Stock Debtors Cash at bank and in hand 12.468 232,405 580.762 18,434 343,858 331,796 512.891 316.467 643.899 109.114 825.635 829.358 694,088 753.013 Liabilities Creditors.. 8mounts f811ing due within one year 17 1322.2671 1315,4531 1280.1761 1266.9821 Not curront 88S8ts 503.%8 513.905 413,912 488.031 Total a88et81088 curront Ilabllltfjo8 6,853.199 6,8e3.738 6.806,581 6.878,702 Creditors. smounts f811ing due after more Ihan one year 1909.3001 1909.3001 1957.4161 1957.4161 Net assets 5,943.899 5,954.438 5.B49,165 5.921,286 FUNOS Resiri¢l8d funds Unre51ricled funds General funds Designated funds lirdudiny revaluation reserve of £4.785,261 12022.. t4.857,2611 23 244.330 244.330 61,777 61,777 23 23 273.687 5,425.882 284.22fj 5,425,882 388,660 5.398,728 460.781 5,398,728 Total unrestricted fund5 5,609.569 5.710.108 5.787,388 5.859.500 Total fund8 5,943.899 5,954.438 S.849,165 5.921,286 The Trustees acknowladg8 their respon8ibi1￿És for complyng with the reouirem8nts of th6 Aciwilh r6SPtct io aecouniing r8¢ords and preparation of financial slaternenls. These fin8nci81 stslemenls were 8pproved by the Trustees o and are signed on their beh8lf by. Stephen Rosser Chair of Trusla6s The notes on pages 2S to 42 forrn part of these financial statement& 23 PENNY BROHN CANCER CARE CONSOLIDATED STATEMENT OF CASH FLOVIS YEAR ENDED 30 NOVEMBER 2023 2023 2022 Not Cash Inflowlloufflowl from oporaiing 8¢tfvitlo8 19 398.016 1328.0091 Non￿peratIonal c8¥h flows.. Inve8tlng oCtIv￿leS Payments for tangib￿ fixed assets Prowds from disposal of fixed 45sels Invèsknenl income 178,7431 1.000 376 1346.1831 348 177,3871 1345.8351 Flnan¢lng a¢tfivltfie8 Loan repayments 171,6831 170,7951 171,6831 170.7951 Not cash Inflowllouiiiowl forth8 year 20 248. 1744.6391 Cashflow Re8trlctlons Charity law prohibits Ihe use of nel cash Infiows on Sny endowed or other restricted fund to offset net cash outflows on any fund outside 115 own oblects. &xcepl on sp8cl81 aLthorlly. In pra¢tlca, Ihls reslrithion has not h8d any effath on Cash flows for the year. The not08 on pa9￿ 26 to 42 lomi part of tho88 flnan¢lal 8tahmot) 24 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 l Aecountlng pollcles Accounting convention The finan¢181 $181emenls have been prepared In Sccordance wrth the historical cost convention (eX￿p1 where olheN4ise slated in the accounting policy nDtel and in accordance with the Slatetnenl of Recomrnended Practice." Accountiw and Reportiry by Charities preparing their 8wounts In accord8nTr wilh the Fin8ncial Reporting Standard ap￿1¢able In the UK and Republic of Ireland IFRS 10211ssued In October 2019, and the Financlsl Reportlrvj Standard 8pplicabl6 in tha Unllad Klnodom and Republlc of Ireland IFRS 1021. aNJ the Companies A 2006. The thatity 15 a pU￿1C benefit entity as defined under FRS102. Golng concern The Charity's forecasts and projections Show Ihatlhe Charity eX￿cts lo oper3te wilhin the level of ils current debt facility. As detai￿d in the annusl report. Ihe Ch8rity seeks lo INrease income from fundraising lo enabk more people lo ac*ss free support lo help them live well with ¢an¢8r. ar￿ alk)w U8 to influence the heallhtsrtr agenda. The Finance and Audit c0mTn￿ee regu13dy reMew various relevant finanaal reports from the Charity. including forecast cash flow scenarios, lo attest posthvaly lo the Ch8ritrfs going concern slalus. Thls review is sh8red with the full Trustee Board 81 esch Trustee meeting. The Charity has two committed loan facilities. It plans lo continue to hold these term debtfacililies, secured on Ihe National Cenlre. that are used lo bridge timing gaps in revenue r815ing. The Charity r8¢eived a £50.000 Bounce bath ban in D8c&mb8r 2020. The loan is 100% 9U8rantsed by th8 Gov&mmtnt repayments coMMen￿d in De￿mber 2021. The Trustees havè a structurèd approach to th8 financial sirstegy of Iht Charty. which includes the 5 ye8r plan rtvitwed by Tmslees annLJalty from which Ihe 12 month budget and cashflow forecast is prepared. Quarterty forecasts are also prepared. Trustees re￿eW and monitorlhe budgei and cash flows al e8th Trustees meeting, Interrogating VarI8n￿$. This continuous moniloriw and control ensures the Trustees are able to property review the Charity's going concem status and 115 financial ￿ability. The TtU51ees rewew the Charity's forecasts and projeGtions al each Board meeting and have a re8sonaNe expectat￿n that the Charily h8s adequate resourTrs lo continue in operation81 existen* for 8 period of al least 12 months fDIIDWing the date of approv81 of Ihese fin8nci81 ststemenls. The Group therefore continues to 8doptthe goin9 Gon￿r￿ basis for preparing ils consolidated financial statements. Basls of ¢onsolld8tlon The Consolid8ted Slalement of Finano81 Acti￿111e$ ISOFAI, Consolid8ted B818nce Sheet 8nd ConsolKlaled Cash Fth Stslemenl con501ilate the financial slalements of the Charity and its subsldlary. PB UK Commerclal Ltd. The results of the subsldiary are Consol￿al￿d on 8 line by crftlul accountlng ludgomonts and key gourco9 of estlmatlon uncoTrtslnty In Ihe applicat￿n of the charty's accounting policies, which are described in this note. Trustees are required to makejudgemenls, estimates awl assumptions 8boul the C?￿ying values of 8ssel$ 8wl118bililies th81 are not readily 8pp8renl from other sources. The eslimoles and undertying assurnpiions are based on historical experience and Other factors tt)at are consKJered re￿Vant. Actual resuhs may differfrom these eslimales. The e51imales and undedying as5Utnplions are reviewed on an orFgoing basi5. Remsions to accounting eslimales are recognised in the period in whith the estimate Is revised rflhe rewsion affects onlythal period or In the period of the rewsion and future periods If the revi%ion affects Ihe current and fuiure periods. In the ￿eW of the Trustees. no assumptions wnceminy firture or ÈslimalK)n uncertainty 8ffe¢tiw assets and liabilities al the balance sheet date are likety lo result in a material adjuslment lo their Cat￿ng amounts in the next finanaal year. The principal accounting policies adopted. judgements and key S￿r¢e$ of esllmallon Jncertalniy in the presenlallon of the finanoal slalemenls are outlined in the folh)wing p8ragr8phs. 25 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 l Aecountlng pollcles Icontlnued Income Income from donations is included In income when these are receivabk. ex￿p1 as folh)ws'. l. When donors spectFy that donaliDllS given tothe charity musl bp used in future accounting periods, Ihe income is defer￿d until those periods., 11. When donor5 impose condthon5 which h3ve to be fulfilled before the charrty becomes enl￿ded lo use Such income, the income is deferred until Ihe pre-condltions have been mel. Legacies are included on a re￿Iva￿e basis where charty Is enlilled lo the income, il can be measured reliabty and re￿Ipl is probable. Where leg8cles have been noiifled 10 the charity. or the charity is 8ware of the granting of prob816. and the Crilerla for income recognllion h8ve not b&n mel. then the legacy is not induded in incotne but is treated as a contingent asset and disdosed if material. Investment incoffle is included on a re￿1¥able basis. Expendlture Expenditure Is re￿nised once there Is a kg81 or conslruclive obl￿allOn lo transfer economic benefrt 10 8 third party. it is prob8ble that a transfer of economic beneffts will be required ITr settlement and the amount of the obligatiDn be measured reliably. Expendilure is classified by actimly. The c051$ of each a¢ll￿ty are m8de up of the lolal of direct costs and sh8red costs. Induding support costs involved in undertaking each activity. Direct CD$ts attributable tD a single aclwily are alloGated direclty to that activity. Shared costs which contribute to more than one actsvily and support Costs whith are not atlribulable lo a single 8Ctivily are apportioned belween those actsvitses on a basis consisiem Wllh the use of the resources. C&Mral staff costs are 811oc81ed on th8 basis of time speni. and deprec481ion charges allo¢al8d on the portion of the asset's use. Expenditure indudes attributable VATwhich cannot be recovered. Raising funds Raising funds expenditure indu¢e$ Ih05e costs Incurred in seeking voluntary contributions, costs of goods sokl and other costs which Illd￿e the costs of runnin9 and psrt￿Ap8ting in fundraising events and co1￿ch0n$ and cost of yODds purthased for resalt. Charitable ActivitiP5 Expenditure on charitable activities wmprises Ihose costs incurred by the Charity in the delivery of its activthes and seNi¢es. 11 includes both costs that can be 8IIoc8ied directly to this acllwfy and those Costs of an indirect nature necessary lo support them. Support COSIS 8nd Other costs that ￿nn0t be direcdy attributed 10 activthÈ$ are allO￿ted on a basis consistentwith the use of the resource. Governance cost5 Goveman¢8 costs indude those ￿St$ assoclstsd with m861ino tha const1lul￿0nal and slalulory r8qulraments of the ¢h8rify snd include the audit fees and costs linked to the strategic management of the charity. Governance costs are included within support costs. Pen8lon costs and other post-rot5￿ment b•neflts The thatity contributes to defined contribution penS￿n sthemes. Contributions payable to Ihe chatity's pension schemes are tharged to Ihe statement of Financial Activitses in Ihe periocl lo which they relate. Intangibl• a8ts&ts Intangib￿ assets costing £500 or more are tspitalised and fft¢0gnised when future economic bÉnÈfrts are probable and the cost orvaluè of the asset Can be measured rdiably. Intangibk assets are inilialty recognised at cosl accumulated amorbsalion and impaitment. Amortisation Is ulcul4tsd $0 as to write off the cost of an asset, less its eslimaled ultimate residual value. over the useful lrfe of that 8ssel as follows.. Website Compuler sotrlare 25% straight line basis 26 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 l Aecountlng pollcles Icontlnued Tangible fixed assets Freehokj building5 are induded al valuation based on open market valuati￿. Valuations are perfortned everyfive years. All olhertangible fL%ed 85sels ore included 81 cost less a¢cumul8led deprec18b-on. T8ngible fixed assets costing £500 or more 8re capilalised and recognise when future econom1¢ banfrfils ara probable and tha cosi or value of asset can b6 messured raliably. The Trustees of the charliy carry out an annual impalrmenl rewew of the propertles. Depreciation Is c8lcul8led lo wrde off the cost orvalualh)n of tangible fixed assets, le55 11$ eslimaled ultimate residual value. over the useful lrfe ofthai sss8t as follows-. Freehokl property Long-temi lèasehokj property Fixiures and fittings Computerequipment 2% straight line on buildings, no depreciat￿n charged on land based upon the length ofthe lease 20'k straight line basis Investment propertles The land and bU1￿1￿9S that Consti￿te the National Centre of Penny Brohn Cancer Care form a mixed use propertywhere e￿fflents of the property are used for charitable purposes and ekments are let or used commerually. As the investment property ekmenls are not sep8rab and Ihe fair value Cannot be measured reliably, the entire property is accountèd for as property within tangible fixed assets. Fixed asset investments Fixed asset investments are a foTm of financi41 instrument 3nd are initially re￿nised al their transaction cost and subsequently measured at fair value al the Bal8n¢e Sheèt dale, unless thè value cannot be m&asLJred rèliaNy in which case it is m&asLJred at cost less imp8im)ent. Investfflenl gains and Ios5. whelher reali5ed or unrealised a￿ comknned and recognised as a gain or loss on inveslments in Ihe SOFA. Investrnenls in subsKliaries and associates are included at cost less impaiTment at 31 March in the accounts. stock Stocks 8r& valued at the lower of cost and n&t rfralisab￿ val￿, aftar making dua allowance for obsoltrt& aNJ slow movirw it&ms. Cost indudes all direct cos15 and an appropriate proportion of fixed and Variab￿ oveFheads. Donaled items are rth valued In stock and are recognised in income only when sold. Cash and cash 8quival6nt8 Cash at b8nk 8nd cash In hsnd includes cash 8nd short temi highty liquid Investments with a Short maturity of three monlh5 or less frorn Ihe dste of a¢ouisition or opening of the deposit or similar account. Financial instruments The ch8ri1y has eèded lo apptylhe pro￿ls1On$ of Section 11 'Basic Finanosl Instruments. and Section 12'01her Financial InslNmenls Issues. of FRS 102 10 all of its financial insimmenis. Fln8nclal instruments are wcognised when tha charlly becomes p8rty to the coniractU81 provSslons of th8 Instrument. Flnan¢Sal assets and liabilities are offset. with the net amounts presented in the financial slalements, when there 15 a legalty enforceable rightto sel offthe recognised amounts and there Is an intention to sellb on a nel basis or lo realise the asset snd sellle 1he118bil1iy simJltsneoJsly. Basr financial assels. which I￿￿Ule Irade 8nd other re￿1¥able5 and cash and b8nk balances, 8re initially measured al Irsnsacbon pri including transaction coslg and subseou8nly Carrièd al amortised Cost usin9 th8 effective interest method unless the arrangement constitutes a financing transaction, where the financial £ssel Is measured al the present value of the future re￿Ipts discounted al a matkel rate of interest. Bas￿ financial Iiabililies. including trade and other payables, and loans from group undertakings. are initially recognised al transadion price unless tha arrangam&nt consllluies a finsnclng transaction, where tha debt instrument is measured al the prasenl v8kJe of th& future payments discounted al a market rale of interest. 27 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 l Aecountlng pollcles Icontlnued Fund accountlng General funds are unrestricted funds which are available for use at the dist¥elion of the Trustees in furtherance of the yeneral objecbves of the Charity and which have nol been deS￿n￿le¢ for olher purp05e5. Dasignaled funds ¢ompris& unr&sirl¢ted funds th8t h8v& bean sel sslde by Ihe Trusleas for particular purposes. Tha aim and use of each designated fund is sel out in the notes to the financial statement5. RestrittÈd funds can only be used for parbcular restritsted pu￿0$*$ within the objects of the Charty. Re$iri¢iions arise when tspecifiÈd by the donor orwhen funds are raised for particular restricted purposes. The costs of raising and administering such funds are charged against the sp6oflcfund. Further explanalK)n of the nattjre arKI purpose of each fund its included in the note$ to the finanrAal stateTnetrts. Investrnenl income, gains and105ses are albcated to the appropriate fund. 2 Incomolrom donatlons and leg8¢109 Group 8 Charlty Unrèstri¢tad Fynds Rg8tri¢tsd Funds Total Fund8 2023 General don3tions Oonations from reyu18rglV&IS Donations to purchase land Legacies 538.123 83.076 206,150 744.272 63,076 26,411 380.049 26,411 147,000 233,049 Total for Group & Charty 834.248 379,561 1.213,809 Priorygar Unrestrittgd Fund$ Restricted Funds Total Furbds 2022 IRestatedl 521.313 60.292 (Restatedl 114,610 IRestatedl 635,923 60.292 256,510 152.548 General don8tlons Donations from regulargiwers Donations to purthage land Lega￿e$ 256,510 152.548 Total for Group & Charty 734.153 371,120 1.105,273 3 Incomefrom charitable activities Group & Charlty Unr88trf¢tod Funds R88trict•d Funds Total Funds 2023 Total Fut)d8 2022 IR*stattrdl 756.500 27,941 8.698 Service gener8ted Income frgm partnerships Other seTvice generated income Catering income 834.462 33.607 10.051 834,462 33,607 10,051 878.120 878,120 793.139 All income r8caived for charitable 8Ctivi118s in the prior yearwas un￿striCted. 28 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 4 Incomefrom othertradlng aetfvltles Unrestrlcted Fund8 Restricted Fund8 Total Funds 2023 Total Fund5 2022 Trading income.. IRo8t¥tedl Faalthes income The Hub PB UK Comm&rC￿1- management charges 61.903 100.408 413,756 61,903 100,408 413,756 23,470 81,742 286,059 Total Charty 576.067 576,067 391.271 PB UK Commerci81 income 4*,310 1413,7561 496,310 1413.7581 237.216 1286.0591 Totsl Group 858.621 658,621 342.428 All income received for other Irading activilps in the prior ye8rwas unreslricled. 6 Exp0ndItu￿ on ralslng Currant yèar Total Funds 2023 Total Furbd8 2022 The Hub Fundraising support costs 116,979 480,068 113.065 589.142 Total Charty 597,047 702.207 PB UK Commerci81- management charges PB UK Commerc181- other trading expenses Inter-group adMIy 413,756 20,972 1413.7561 286,059 23,714 1286.0591 Total Group 618,019 725.921 6 Expenditure on charitable activf(ies Support Costs (Noto 7 Dlro Cotst8 Totsl Funds 2023 Group & Charity Onlinè Serv￿*$ In-personlgroup servi Ona to ona services Partnerships 168.OS6 24.937 184.499 704.311 269.845 86,513 12,837 94,978 362,572 138,914 254,569 37.774 279,477 1.066.883 408.759 Group & Charity totals 1,351.648 695,814 2.047,462 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 6 Expendlture on charltable actlvkles Icontlnuedl Support Costs (Note 71 Prioryear Direct 08t8 Total Fund5 2022 Onlire setvKes In personl group servi￿5 Ona to ona services Partnerships 135.499 32.527 238.711 736.213 388.034 51,478 12,358 90,691 279,700 147,421 186,977 44,885 329,402 1.015,913 535,455 Gmup & ¢harlly lola18 1,530.984 581,848 2.112,632 7 Support costs Support costs are allocated belween Tai5iry fijnds and Charitab￿ activities Dn thp basis of staff lime. Support C051s. included in notes 5 & 6. are 3s follows.. urrent year Fundralslng and publl¢lty Charitab Act[￿tIeS Total 2023 Staff costs Other costs offi* costs Building costs Fin8nce costs GOve[nan￿ costs 310.496 73.917 28.955 53.162 6.ey 6.884 210,426 520.922 73,917 175.882 322.923 40,421 41,817 148,927 269,761 33,767 34,933 Group & charitytotals 480.068 695 814 1 175.882 Prfor yeor Fundral$lng and publicity Charitabltr ActMtie5 Total 2022 Staff costs other costs offi￿ costs 8uildin9 costs Fin8nce costs Governan￿ costs 318.513 202.383 27.401 28.952 8.674 3.219 226,715 545.228 202.383 169.907 179.522 53,787 19,963 142,506 150,570 45,113 16,744 Group & charitytDtals 589,142 581,648 1,170,790 B Net Incomellexpendlturel forthe year This Is slated 8fter ¢horging'. Group Charfty 2023 2022 2023 2022 Audllor's remunerallon - for stslutory 8udlt services for accounts preparation 12.150 3.800 15.114 8,800 2,300 Trustses, r8mun8raiion Trustees, Iravel. meelirbJ and IrainitJJ expenses- 1 trustee12022' 1 Iru51eel Amorbsalion Depreciation 64 17.271 99.081 114 17.280 98.97fj 84 17,271 99,081 17,280 98,976 Donations from Truslees and rdsled parties amounled to £1.72012022'. £1.4701. 30 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 9 Staff costs and number5 The aggregate payroll costs were. Group Charfty 2023 2022 2023 2022 W8ges & s8kries Social securty costs P8nsion contributions Redundanry payments 1.667.778 130.13g 78.774 9.368 1,714.781 139.390 82.318 52.868 1.667,778 130,139 78,774 9,368 1.714,781 139.390 82,318 52,868 1,886.059 1,989.357 1.886,059 1.989.357 The averaga weekly number of employees Ilnrluding senior Manag8men￿ead8rgh1p leaml durSng year was.. Group Charfty 2023 2022 2023 2022 Stsff 106 109 106 109 The number ofemployees whose employee benefits lexduding employer pension costs) exceeded £60.000 was.. Group Charity 2023 2022 2023 2022 £60.000 469.999 £70,000- £79,999 Kèy managomgnt pevsonnel The lolal em￿Oyee beneffts of the key management per50nnd for the ye8rw85 £80.30612022.. £183.5511. 10 Taxatlon The ch8rffy Is axempl from corporation lax on Ils charftsbla acuvthes. 31 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 11 Statement of Flnanclal Actlvkles comparatlve flgure5 Group Fortho yoarondod 30 November 2022 Unrestricted Fund8 Restricted Funds Total Fund5 2022 Incomefrom.. Donation$ and legacies Charil8bk 8Ctivilies Othertrading activities Invesbnenls Olher income IReststedl 734.153 793.139 342.428 348 2.500 (Restated) 371,120 IRe5tatsdl 1.105,273 793.139 342.428 348 2.500 Total Incoffle 1,872.568 371,120 2.243.688 Expendlture on.. Raising funds charitab￿ activities 725.921 1.661.566 725.921 2.112,632 451,066 Total expenditure 2,387.487 451,066 2.838.553 Net incomellexpenditurel forthe year 179.9461 1594.8651 Transfers between funds 70,375 170.3751 Net movement bthe?n funds 1444,5441 1150.3211 1594.8651 Total funds at stsrt of year 6,231.932 212,098 8.444,030 Total funds at end of year 5,787.388 61,777 5.849.165 Charity For the yeayended 39 November 2022 Unrestricted Funds Restricted Funds Total Fund5 2022 Incomefrom.. Don81ions and legacles Charilabk 3Cti¥ilies Othertrading activities Invesimenls Olher incoFne IReststedl 734.153 793.139 391,271 348 2.500 IRe$tatedl 371,120 IRestatedl 1.105,273 793.139 391.271 348 2.500 Total incorne 371,120 2,292,531 Expenditure on.. Raising funds charitab￿ activitses 702.207 1.661.566 702.207 2.112.632 451,066 Total trxpenditurg 2,363.773 451,066 2,814,839 Net incomellexponditurel forthg year 1442,3621 179.9461 1522,3081 Transfers beiwepn funds 70,375 170.3751 Net movement bE￿een fund$ 1371,9871 1150.3211 1522.3081 Total fund$ at stsrt otyear 6,231.496 212,098 8.443,594 Total funds at end of year 5,859,509 61,777 5,921.286 32 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 12 Intan9lble 3S5ets Comput•r Software Group and charity Website Total Cost At 1 DeTrmber2022 38.788 86,360 125.148 Dlsposs 38,7881 138.7881 At 30 November 2023 86,360 86,360 Amortl8atio At 1 De￿rnber 2022 Charge for tha y88r 38.788 57,588 17,271 ,376 17,271 138.7881 138.7881 At 20 November 2023 74,859 74,85g Nei Book Valuo At 30 November 2023 At 30 November 2022 28,772 28,772 13 Tanglble Ilxod a880ts Long.term leasehold propevty Freehold property Flxture$ an rrttings Computsr equiprrbent Group aftd charity Total Cost or valuatlon At 1 De￿rnber2D22 6.754,337 117.789 69.613 58.790 18,1061 45,429 19,953 6.087.168 78,743 le.3￿) DIsPOS2 12001 At 30 November 2023 6.754,337 117.589 120.297 65,382 7.057.605 Dgpre¢latlon At l De￿fflber 2022 Charge for the yesr Eliminated on disposal 540,700 71,300 35,138 12.059 28.863 10.531 25,135 5,191 629,836 99,081 At 30 N0vemt￿r 2023 612,000 47.197 35.881 30,326 725,404 Net book value At ao November 2023 6.142,337 70.392 84.416 35,056 6.322.201 At 30 Novemtkr 2022 6.213,637 82.651 40.750 20,294 6.357.332 is Penny Brohn Canter Care's pdicyto revalue freehold property èvery S years. The ffftehold prDpertywas revaI￿d in Au9USt 2019 by Jones Lang Lasalle timiled. a firm of valuers extemal lo the Charity. The propety's open market value was considered to be £6.100,OOD accordance wllh the RICS valuation mode. The hisiori£*l CD$t of the revalued ffreeho￿ property assets atnounls ID £1,356.376. 33 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 14 Flxed asset Investments Group Charfty 2023 2022 2023 2022 Ll81od In￿stments At 1 De￿t￿ber2O22 unreal￿ed gainl Ilossl Unlistod invèstmènts Investment in subsidiary 6.565 14361 6.565 6,565 14361 6,565 6,129 6.565 6,131 6,567 Shares In group undertakings and partiupating interests.. Sub8ldfjary Undertakings Total Co$t At 1 December 2022 and ai 30 November 2023 Detai15 of undertakings= eountry ol Incoyporatlo Proportion of voting lights and 8har88 hold 2023 2022 Compat)y nama Holdlt)g PB UK Commerci81 Ltd England 8nd Wales Ordinary 100* 100% Prfn¢lp•l 8¢tlv6tlg8 Other retail salp Df new goimls in specialised stores Other retail s81e not In stores, stalls or mart(els Other accoTnmodation PB UK Commerclal Lttl Year entlod Y￿r ended 30 Nov 2023 30 Nov 2022 Tumover Cosl of 58les 496,309 1427.3fj21 237,201 1309.0041 Gro88 proflt 68,947 171.8031 Adminislralwe expenses 17.3631 11.1541 0￿￿tIng profrt 61,584 172.9571 Inieregi payable and similar chary&s 400 Profit before taxation 61,584 172,5571 Tax charge forthe year Protit forth? perlod 61,584 172.5571 Retained eamings brought forw8r 436 Retalned earnlng$ carrfed forward 10.537 72.121 34 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 15 Stock Group Charfty 2023 2022 2023 2022 Flnlshed goods and goods for ressle 12.468 18.434 16 08btor6 Group Charfty 2023 2022 2023 2022 ¢R￿￿ted) 216.637 IRo8iatodl 201,605 287.594 38,732 115.968 Trade debtors Amounis owed by group undertakiws Olher debtors PrÈpaymenl$ and acfmed In￿Me 105,112 76,334 309,459 1,450 125,648 1.645 125.648 115.990 232,405 343.858 512,891 643.899 17 Cr8diiors'. amourbts falling duo within on6 y8ar Group Charlty 2023 2022 2023 2022 IRestst8dl 29.103 9.727 81.158 39.562 18.494 102.132 IRo8iatodl 29.103 9,727 76,998 34,554 15,639 100,961 Bank loans Other h)ans Trade creditors Othertaxation and goual security 30.114 9.973 114.617 74.431 27.903 65.229 30,114 9,973 114,012 74,342 27,603 59,409 Acuuals and deferred income 322,267 280.176 315,453 266.982 Loan facilities are ￿th Natwesl Bank and Triod05 Bank, secured on the fr￿hOld property of the Charity. Dgferrgd Income Group harlty 2023 2022 2023 2022 At 1 December 2022 Amounts released from previous periods Resources deferred in the Feriod 8,744 18,7441 10.597 41.215 7,573 17.5731 10,597 41,215 8.744 7.573 At 30 Novèmbèr 2023 10,597 8.744 10,597 7.573 18 Crediiors.. amounts falling due after one year Group harlty 2023 2022 2023 2022 IRo8tstodl 926.039 31.377 IRoStattrdl g26.03g 31,377 Bank loans Othtr k)ans 887.706 21,594 887,706 21,594 909,300 957.416 909,300 957.416 Loan facilities are with N8tWe$i Bank and Triodos Bank, secured on the freehold property of the Charity. 35 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 19 fteconelllatlon of net movement In funds to net cash Inflow from operatlng actI￿tIeS Group 2023 2022 statemènt Df Financial Activibets. Nel movement in funds Loss gn investments Loan interest Invèslmenl income Loss on disposal of fixed a55el Amorbsaiion Depreci8lion Increase in operational creditors.. current liabilities Oècre8se in opèr81ional debtors Decrease in stod( 94,734 436 24,824 13761 3,793 17,271 99,081 40,834 111,453 5,966 1594.8651 47,757 13481 18,000 100,811 26.415 72,998 1,223 Net cash inflowllouffiowl from operating actMtie5 398,016 1328.0091 20 Analysls of changes In cash durlng the year 2023 2022 Chang8 Cash at bank and in hand 580,762 331,796 248.966 2022 2021 Change Cash at bsnk and in hand 331.796 1.076,435 744.639 21 Analy818 of ¢hathg88 n8t dobt Currant wr At1Do¢ 2022 0pora￿D9 cash flows Investlng cash flow5 Flnanclng cash flows At 30 Nov 2023 Cash at b8nk snd in hand Debt due within one year Debt due after more than one year 331,796 138.8301 1957,4161 398.016 177,3671 171.6831 11.2571 48,116 580.762 140.0871 1909,3001 Totsi 664.450 77,367 24.824 368.625 36 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 22 Movement In funds At1Do¢ 2022 Incomp and gains Expenditure and 105se5 At 30 No¥ 2023 Forthe yearended 30 November 2023 Transfer5 Restricted fund5 Bristol VVhDle Life Approach in Scolland Homeopathic pilot Llbrary Residential Retreats & Wellbeing Days Lymphoèdema IRestatedl 11,288 9,000 8,500 12,580 22,852 11.288 19,0001 7.293 112,5801 150,1381 115,2501 147,000 15.250 458 119.714 One to One Other small donations Penny Brohn on the High Street Regional donations Relaxaiion chairs Remote Se[vi￿s Treatment SuppDrt W8lk the W8lk Land fund 2,704 230 51,297 141,2621 11,8001 12,6201 149,1001 12,8381 156,2751 10.035 1.800 4,895 11,000 2,296 2.275 38.100 $42 150.000 26.411 93.725 174.8661 48,454 379,$61 245,462 244,330 Unrestrf¢t0d fundg Designated fund5 Cspit81 fund In￿udI￿ revaluatlon reserve General fund 5.398,728 460,781 168,330 1216.7841 5.425,882 284.226 2,298.536 12.258,3071 5.859 509 2 298.536 2.399,483 48,454 5 710.108 Total fund8 Charity 5.921,286 2,678,097 12.644,9451 5.954,438 PB UK Commerci81 Ltd 4*,309 1413,7561 1434,7271 413.756 110.5371 72.121 82.553 20,971 10.539 Total funds Group 5.849,165 2,760.650 12.665,9161 5.943.899 37 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 22 Movement In funds Icontlnuedl Forthe yearended 30 November 2022 AtIDec 2021 At 30 Nov 2022 In¢om8 Expondlturo Transfor8 Re8tdctsd fund8 Bristol VlhDle Lrfe Approach in Scoland Buildings al Nali¢n81 Centre IR08tatsdl 11,288 4,732 25,000 50,938 7,041 IRe8Utsdl IRestst8dl IRo8t8todl IRe8tstsdl 11.288 14,7321 125,0001 150,9381 110,2061 Communty Eng898meni Garden Homeopathic pilot Library Residential Retreats & Wellbeing Days Living Well Programme Lymphoedema Nutrition One to One Other small donations Penny Brohn on the HvJh Street Reyional don81ions Relaxation ch81rs Remoté Services Trealmenl Support Trust income Land fund 3.165 9.000 8,500 9.000 8,500 12.580 15,713 20,000 13,1331 120,0001 1238,1481 14,0561 18,5001 12,0001 13,7031 110,2951 261,000 22,852 4,056 11,204 2.000 30.000 10,295 2.704 230 51.297 230 25,000 4,895 39,247 1,678 2,280 4.895 11,000 2.296 30,$00 9.94e 158,7471 19,3281 12,2801 256.510 1331.3751 174.8651 212,098 451,086 70.375 61.777 Unre$trfcted fund¥ Designated funds C3Pital fund Indudiw revaluation reserve General fund 5.167.353 1.(64,143 1100.0001 12.263,7731 331,375 1261,0001 5.398.728 460.781 6.231,496 1,921.411 2.363,773 70,375 5.859,509 Total fund8 Charlty 6.443,594 2,292.531 12.814,8391 5.921.288 PB UK Commercl81 Ltd Inler-entsty transadions 438 237.216 1286,0591 1309,7731 286.059 436 48,843 23,714 72,121 Total funds Group 6.444,030 2,243.688 2.838,5531 5,849.165 R•8trf¢tsd fund8 Brf8tol Wholo Llfe Appro8¢h In Scotland The Bristol Whole Life Approach in Scotland was a pilot projectto work in partnershipwrfh Dumfries House in Ayrshire, gmng us the thance lo tske our Brisiol Whole Life Approach lo those living with Can￿r in Scotland. Building8 at National Cofbtro Funds were ￿e￿ived from The P051code Locgl Trust lo help r&open the N8lional Centre post COVID for both commerual venue hire and this ytar for people with cancer. Community Engagement The Income from The Prince of Waks Foundallon was re-purposed. followlng dSscusslon with Ihe Foundallon, lo other projects 8nd core SeM￿S during this financial year. 38 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 22 Movement In funds Icontlnuedl Garden Funds were received from The Clark Foundation for the purchase of garden fUrn￿re. We received a private donation to payforthe repair of the Folly. Funds rsised from plant ssles al the NGS open garden day are reinvested Inlo ourTherapeulic Gsrdens. Wailrose Community Funds made a donation to be used within ourgreen space. Hompopathic pilot A grsnl was received from Nelsons lo run 8 Homeopathy project with the NalSonal Centre for Inlagrallve Medlcine INCIMI provldSng indivkjual consullalions to Penny Brohn UK Clients. Llbrary Funds were originalty received for U￿aling resources, shelving and IT within the James Tudor Library from the James Tudor Foundation. In 2023 permission was gr8nled by the James Tudor Foundation to re-purpose this grant lo enable us to purchase new books and resour*s, refresh the library space and Create a staff placement to SUPPDrt Ihe online resources. ftesldentlal Retreats & Wellbelng Days Funds had been received in prior ye8rs to support those attending our In-person relrests and wellbeing days. Lymphotrdèma A restricted legacywas re￿IVed to make special facilities available lo Ihose clEn15 suffering wrfh LymphoedeTna. The transfer in Ihe year is where spending applicable lo Ihe restriclion was Inilialty carried out froyn gener81 funds. Nutr￿￿10n Gerald Micklem Charltsbb Trust suppori the salary Costs of our n￿tr￿on lead who Is responslbk for leading and mansging the developmenl and delivery of safe. effective, high quality onlinÈ and irFpèrson nuiribon services. Sir Char￿5 Jessel Charitable Trust also gave a donation in support of nutrition servi¢e5. Ono to Ono Funds were received in November 2022 from The Weinstock Fund and during the cutrentyearfrom The Annett TTUSI for One-tfrone's wth an Int￿ratiVe doctor. oth8r small donatlon8 A donation had been received in a prior yearto cover the cost of movement exercxse. Penny Brohn on the Hlgh Street Restricted funds had been recewed from the Newby charitab￿ Ttusl to provide Psythobgical services at The Hub. This face-to-face service provision was delayed due COV￿ reslriclions. R•glot)al donatlons Donations were re￿IVed from The Waller Guinness Charitable Trust to support our online Se￿￿9 lo Ihose liwng in Wiltshire and a donation was re¢aived trom Burgess Salmon lo support those living In Bristol. Relaxation chairs The relaxation chairs is a grant lo enabk us lo upgrade and replace our relaxation chairs. Romote S8rylc We continue lo provide our pmgramme of onlirE support throughout Ihe year With national re8c4) for pe¢￿e Sffected by cancer. ¢onlinually reviewing and adapting our offering. These funds have enabled lo grow this se￿￿ and embed it as part of our hybrid service model. Grants have been received from ￿llIe Johnson Charilable Trust. He118nlhus Ch4rilable Trust, Webb Family Charitable Trust and The Tim Tiley Bursary Fund. Treatment Support Our online Trealmenl Support Programme was supported by a grant from The Annel Charitable Trust. Walk th8 Walk A gr8nl was re*ived trom Walk the Walk lo bring back our in-person services once again through the inlroductson of speciali51 Wellbeing d8yS 8nd residential reirests. 39 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 22 Movement In funds Icontlnuedl Land fund Fund restricted to the purchase of adjacent land to the National Centre and associated cos15. The transfer in the current year represents the spend above restricted income. made trom general funds. The negative brought fO￿ard balan* was left In snliupalion of restricted funds yel lo be re(Eived. Counselling Support was re¢*ived from the Newby Trust Ltd to support our counselliw progrsmme Ihrouyh the fijnding of a counsdlorwho would offèrs one-lo-one counselling, and facilitating an emotional support group. Dgslgnated funds Capltal fund and rovaluaiion Y89orv8 The Capital fund represents the nel book value of laryible and inlaryible fixed assets, less k)ans seGured on the relevant assets. The revaluation reserve lo18ts £4,785.261 12022.. £4.857.2611 at the yearend. 23 Anolysls of net assets between tuntls harfty As at 30 NOveM￿r 2023 Unwtrlcted D*sigrbatèd Gon•ral Fund$ Funds Rotstri¢t8d Funds Total 2023 Tangible fixed assets Intangib￿ fixed asstts Fixed assel investments Current assets Crediiors due within one year Creditors over one year 6,332.201 6,332.201 8,131 585,028 1285.3391 121.5941 6,131 829.358 1315.4531 1909.3001 244.330 1887,7061 Total charity 244.330 5,425.882 284,226 5.054.438 As at 30 November2022 Unrestricted 09819nat8d G8noral Funds Funds Ro8trl¢t8d Funds Total 2022 Tangible fixed assets Inlangibk fixecl assets Fixed asset investmen15 Current assets Creditors within one year Creditors over one year 6,357,332 28.772 6,357.332 28.772 6,567 753,013 1266.9821 1957,4161 6,567 723,470 1237.8791 131.3771 61,777 132,2341 129,1031 1926,0391 Total ¢haiity 61,777 5,398.728 460,781 5.921,266 40 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 23 Analysls of net assets between funds Icontlnuedl Group As at 30 Novombor 2023 Unrestrlcted Doslgt)atod G8n•ral Funds Fund5 Ro8trl¢t8d Funds Total 2023 Tangible fixed assets Inlangibk fixed assets Fixed asset investments Current asgets Credilors due within one year Creditor5 over one year 6,332.201 6,332.201 6,129 $81,305 1292.1531 21.5941 6,129 825,635 1322.2671 1909.3001 244,330 1887,7061 Total Group 244,330 5,425.882 273,687 5,943,899 As at 30 Novembpr2022 Unrestricted Deslgnated General Funds Funds Re8trl¢ted Funds Totsl 2022 Tangible flxed assals Inlangibk fixed assets Fixed asset investments Current assets Creditors due within one year Cr6diiors over one year 6,357.332 28.772 6.357.332 28.772 6,565 894.088 1280.1761 1957.4161 6,565 664,545 1251.073} 131.3771 61.777 132,2341 129,1031 1926,0391 Total Group 61,777 5,398.728 388,660 5.849,165 24 o￿latIng 16880 commltments At 30 Novem1￿[ 2023 the company had commitments to make future minimum lease payments undernon-cantellable operating leaseg as follows. 2023 2022 ounts payable.. Within Dn6 year Within two and fve year Wrthin overfive years 44,513 170,094 52,500 44,513 172.607 04.500 267,107 311,620 25 Related parties Trustees 8re able lo make use of the 4ccommodalion 81 the Nation81 Centre when ollending on business and usualy provide a donation in respect of Ihis. No Trugieeg were provKJed any nights 8C¢QtllmDdation in the ye8r12022. Nill. There are no transactions with trustees or other related partEs otherthan those disdosed as required by the SORP elsewhere in the financial statements. 26 Prior*trriod r&8tat6mènts The alk)cation of ￿rtain items of income and eyndilure in the prior-yearwa5 found to need correction. Total income. expenditure or funds Were not aller8d in Ihls respe￿. Ewndilure tolalling £238.148 was made OLrt of general funds in the prior-year. bul related lo the reslricled fund'Lymphoederna'. The prior- year restsiemenl 8110¢8ies this 6xpendiiure against the fund. raising prlor-ye8r restricted expenditure and brought forwsrd gewral funds by £238,148. reducing general fund eynditure and brought fotward restricted reserves respeclwely. 41 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 30 NOVEMBER 2023 26 Prfor-porlod restst8ment8 Iconllnuedl Legacy income totalling £31,376 was not recognised in a prior year. yet required acuuing. The changes are as follows. 2021 2022 2023 Debtors increase Le9a¢y income lincr8aseyde¢re8St Unre51ricled fijnds broughtfoTward increase 61.376 161,3761 31,376 30,000 61.376 31,376 11 was found ih81 income recognised 8s unreslricled in the prior-ye8rw8s received for restricted purposes towards the purchase of18nd. The impact of the correction was to increase prior-year restricted income by £256,510 and related capital expenditure of £331,375, inGreasing designated funds brought fotward by £74.866 and red￿fig restricted funds brought forward The Impath of all the above changes are shown below.. Group 2022 A8 prevlou81y stated 2022 Ro8tatod amounts Analy818 by a888t8 Adjustment Intangib￿ assets TangibleAssel$ Investrnenls Slo¢k Debtors Cash at b8nk and in hand Creditors <1 ye8r Creditor5 > 1 year 28,772 fj.357.332 6.565 18.434 312.482 331,796 1312,7001 1924,8921 28.772 6.357.332 6.565 18.434 343.858 331.796 1280.1761 1957,4161 31,376 32,524 132.5241 5,817 789 5 849.165 2022 A8 prevlou8ly stated 2022 Ro8tatod amounts Analy818 by lund$ Adjustment Restricted funds Unrestricted funds General funds Desiyn8ted furKJs 374,790 1313.0131 61,777 119.137 5,323.862 269,523 74,866 388.660 5.398,728 5,817.789 31,376 5.849.165 All ofts prior year ￿$tatements ￿late to the ¢h8rity only. 42